Formulation and Evaluation of once daily sustained release matrix tablets of Aceclofenac using natural gums by Kumar, Sunil et al.
Singh et al                                        Journal of Drug Delivery & Therapeutics; 2012, 2(1)   16 
© 2011, JDDT. All Rights Reserved                                                                                                                                                                                     ISSN: 2250-1177 
Available online at http://jddtonline.info 
RESEARCH ARTICLE 
FORMULATION AND EVALUATION OF ONCE DAILY SUSTAINED RELEASE MATRIX TABLET OF 
ACECLOFENAC USING NATURAL GUMS 
Prajapati SK, Richhaiya R, Singh VK, *Singh AK, Kumar S, Chaudhary RK 
Institute of Pharmacy, Bundelkhand University, India- Jhansi-284128 
Correspondence Author’s Email: singhanup1984@gmail.com 
Received 04 Dec 2011; Revised 29 Dec 2011; Accepted 10 Jan 2012, Available online 20 Jan 2012 
 
 
INTRODUCTION 
Hydrophilic polymers are becoming very popular in 
formulating oral controlled-release tablets. As the dissolution 
medium or biological fluid penetrates the dosage form, the 
polymer material swells and drug molecules begin to move 
out of the system by diffusion at a determined rate by the 
nature and composition of the polymer as well as formulation 
type. 1, 2, 3, 5 
The use of naturally occurring hydrophilic biocompatible 
polymeric materials has been focused in recent research 
activity in the design of dosage form for oral controlled-
release of drugs compare to synthetic polymers. The use of 
matrix devices to control the release of a variety of 
therapeutic agents has become very important in the 
development of controlled release dosage forms. The 
hydrophilic natural gums hydrate and swell on contact with 
water and these have been used for the preparation of single 
unit dosage forms. Also, the natural gums selected have an 
economic importance in being cheaper than many processed 
synthetic gums available. 2,7,8  
The use of hydrophilic polymers like xanthan gum (FX) and 
karaya gum (FK) alone and combination was used in this 
study for oral controlled release dosage forms. The Xanthan 
gum is water soluble, anionic-bacterial heteropolysaccharide, 
 
 while FK is a neutral plant galactomannan. Both materials 
have been extensively studied in a range of environment, 
with some sensitivity to pH and ionic strength demonstrated. 
The synergistic gelation of FX and FK has also been reported 
to decrease dramatically below pH 5, although it is 
independent of pH within the range of 5-10. Xanthan gum 
and FK are water soluble thickening agents, but when they 
are mixed, an original gelation occurs. The hydrophilic 
matrix system being investigated that two 
heteropolysaccharides are the principle of the formulation it 
utilizes the synergistic interaction of two biopolymers to 
control the drug release process. 3, 6 
Aceclofenac is a potent non-steroidal anti-inflammatory 
drug, which is commonly prescribed drug for the treatment 
of patients suffering with pain, rheumatoid arthritis, 
osteoarthritis and ankylosing spondylitis. It is a weak acid 
(pKa =4.7) practically insoluble in water and acidic 
environment. The oral absorption is uniform, rapid and 
complete with a bioavailability of nearly 100% and an 
elimination half-life of 2-4 h. Aceclofenac is reported to have 
a short biological half-life (3.4 ± 0.7) requiring to be 
administered in 100 mg twice daily. Hence we have selected 
Aceclofenac for development of once daily sustained release 
matrix tablets. The pharmacokinetics and dosage schedule 
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supports once daily sustained release formulations for 
Aceclofenac for better control of pain, enhance clinical 
efficacy and patient compliance.10 
The objective of present investigation is design and evaluates 
once daily sustained release tablets of Aceclofenac using 
natural gums (xanthan gum and karaya gum) as release 
retardant. Drug release from hydrophilic matrices is known 
to be a complex interaction between swelling, diffusion and 
erosion mechanisms. Previous work has demonstrated that 
naturally occurring FX has useful hydrogels for producing a 
constant in-vitro drug release. This work was an attempt to 
determine the relative contribution of the drug release 
mechanisms from Aceclofenac matrix tablets produced with 
xanthan (FX) and the highly hydrophilic karaya gum (FK). 
Different concentrations of gums, alone (FX or FK) and in 
physical mixture (FXK) of FX and FK in 1:1 ratio were 
tested to evaluate their performance as release-controlling 
agents. 5, 14 
MATERIALS AND METHODS 
Materials: 
Aceclofenac gift sample obtained from Pharma Synth 
Formulation Ltd 22/6B, Sidcul-IIE, xanthan gum (FX) was 
obtained from Maruti Pharmaceutical Ltd, india, karaya gum 
(FK) from Colorcon Asia Pvt., starch-1500 from Colorcon 
Asia Pvt. Limied. Talk and magnesium stearate were 
analitycal reagent grade and used without further 
putification. 
Preparation of matrix tablets (Direct compression method)  
Once daily sustained release matrix tablets of Aceclofenac 
with xanthan gum and karaya gum were prepared by using 
different drug: gum ratio viz. 1:0.500, 1:0.625, 1:0.750, 
prepared by direct compression technique and the 
formulations were name as  FX1, FX2, FX3, FK1, FK2, 
FK3, FXK1, FXK2 and FXK3 respectively (table 1). All the 
powders were passed through mesh # 80. Talk and 
magnesium stearate were finally added as glidant and 
lubricants. The drug and powdered gum were compressed 
(10 mm diameter, biconvex punches) using a single punch 
tablet compression machine (Cadmach, Ahmedabad, india) 
prior to the compression, the powdered gum was evaluated 
for several tests. 4,5,8,9,10,11, 17 
Table 1: Composition of once daily matrix tablets (400 mg) 
F. Code. Drug  Xanthan  Karaya  Starch  Mg.  Total  
(mg) gum(mg) gum (mg) 1500 Stearate (mg) 
       
FX1 200 100 - 95 5 400 
FX2 200 125 - 70 5 400 
FX3 200 150 - 45 5 400 
FK1 200 - 100 95 5 400 
FK2 200 - 125 70 5 400 
FK3 200 - 150 45 5 400 
FXK1 200 50 50 95 5 400 
FXK2 200 62.5 62.5 70 5 400 
FXK3 200 75 75 45 5 400 
 
EVALUATIONS 
Evaluation of Powdered gum 
Angle of Repose tablets (Fixed Funnel Method) 10 ,16,17 
The angle of repose of powdered gum was determined by the 
funnel method. The accurately weighed powders were taken 
in funnel. The height of funnel was adjusted in such a way 
that the tip of funnel just touched the apex of the heap of 
powder. The powder was allowed to flow through the funnel 
freely onto the surface. The diameter of powder cone was 
measured and angle of repose was calculated using the 
following equation  
θ = tan –1 (h/r) 
Here h and r are the height and radius of the pile respectively 
Bulk Density tablets  
Both loose bulk density (LBD) and tapped bulk density 
(TBD) were determined. A quantity of 2 g of powder from 
each formula, previously lightly shaken to break any 
agglomerates formed, was introduced into a 10 ml measuring 
cylinder. After the initial volume was observed, the cylinder 
was allowed to fall under its own weight onto a hard surface 
from the height of 2.5 cm at 2 second intervals. The tapping 
was continued until no further change in volume was noted. 
LBD and TBD were calculated using the following formulas. 
LBD = Weight of the Powder/Volume of the packing 
Singh et al                                        Journal of Drug Delivery & Therapeutics; 2012, 2(1)   18 
© 2011, JDDT. All Rights Reserved                                                                                                                                                                                     ISSN: 2250-1177 
TBD = Weight of the powder /Tapped volume of the 
packing. 10 
Compressibility Index tablets  
The compressibility index of the gum powder was 
determined by Carr’s compressibility index. 
Carr’s Index (%) = (TBD – LBD)/TBD X 100 
 
Drug Content tablets  
An accurately weighed amount of powdered matrix tablets 
(400 mg) was extracted with water and the solution was 
filtered through 0.45µ membrane (Nunc, New Delhi, India). 
The absorbance was measured at 274 nm after suitable 
dilution. . 9,10,14 
The above physical properties of formulated matrix tablets 
were shown in Table 2 
Table 2: Micromeritic properties of matrix tablets 
F. Code Angle of  Bulk density  Tapped density  Hausner  Carr’s  
repose (θ)  (gm/cm3)  (gm/cm3)  ratio (HR)  index 
      
FX1  22.20±0.19  0.685±0.006  0.754±0.008  1.10±0.011  9.15±0.94  
FX2  21.89±0.28  0.688±0.010  0.771±0.011  1.12±0.02  10.76±2.07  
FX3  21.20±0.49  0.692±0.005  0.773±0.008  1.11±0.011  10.47±1.60  
FK1  23.27±0.30  0.690±0.01  0.764±0.002  1.10±0.015  9.68±0.94  
FK2  23.01±0.24  0.679±0.009  0.771±0.01  1.13±0.001  11.93±0.88  
FK3  21.93±0.29  0.687±0.004  0.762±0.011  1.10±0.02  9.84±1.75  
FXK1  21.78±0.60  0.682±0.004  0.758±0.01  1.11±0.02  10.02±1.65  
FXK2  21.74±0.72  0.667±0.009  0.775±0.06  1.16±0.011  13.93±0.84  
FXK3  22.05±1.00  0.678±0.005  0.774±0.05  1.14±0.02  12.40±1.71  
      
Evaluation of Tablets 
Thickness tablets  
The thickness of the tablets was determined using a thickness 
screw gauge (Mitutoyo, New Delhi, India). Five tablets from 
each batch were used and average values were calculated. 10 
Uniformity of Weight tablets  
To study weight variation, 20 tablets of each formulation 
were weighed using an electronic balance (Denver APX-100, 
Arvada, Colorado) and the test was performed according to 
the official method. 3, 6, 7, 10 
Hardness and Friability tablets  
For each formulation, the hardness and friability of tablets 
equivalent to 6.5g were determined using the Monsanto 
hardness tester (Cadmach, Ahmedabad, India) and theRoche 
friabilator (Campbell Electronics, Mumbai, India), 
respectively. 10 
Swelling behaviour of Sustained release matrix tablets 
tablets  
The extent of swelling was measured in terms of % weight 
gain by the tablet. The swelling behavior of formulations 
FX1, FX2, FX3, FK1, FK2, FK3, FXK1, FXK2 and FXK3 
were studied. One tablet from each formulation was kept in a 
Petri dish containing pH 7.4 phosphate buffers. At the end of 
1 hour, the tablet was withdrawn, kept on tissue paper and 
weighed then. This procedure was repeated till 8 h. The % 
weight gain by the tablet was calculated by the following 
formula. 3,6,10 
                       S.I = {(Mt-M0) / M0} X 100 
 Where, S.I = swelling index, Mt= weight of tablet at time‘t’ 
and 
 Mo = weight of tablet at time t = 0. Swelling behavior of 
sustained release matrix tablets were represented in figure 
In-vitro release studies tablets  
The in vitro dissolution studies were carried out using USP 
apparatus type II at 50 rpm. The dissolution medium 
consisted phosphate buffer pH 7.4 for 24 hours (900 ml), 
maintained at 37°C ± 0.5°C. The drug release at different 
time intervals was measured by UV-visible 
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spectrophotometer (UV spectrophotometer, Shimadzu 1700, 
Japan) at 274 nm. It was made clear that none of the 
ingredients used in the matrix formulations interfered with 
the assay. The release studies were conducted in triplicate (5 
tablets in each set) and the mean values were plotted versus 
time with SDs of less than 3, indicating the reproducibility of 
the results. 3,9,10 
Table 3: show the Evaluation parameters of matrix tablets 
F. Code Thickness % friability % Drug  % Weight  Hardness  
(mm)  content variation (Kg/cm
2 
) 
FX1 6.00±0.00 0.69±0.04 92.85 ±2.40 2.23±1.4 4.23±0.15 
FX2 6.00±0.00 0.52±0.04 94.91±2.21 0.93±0.87 4.46±0.15 
FX3 6.00±0.00 0.54±0.07 99.63±1.71 1.64±1.63 4.60±0.20 
FK1 6.00±0.00 0.39±0.09 93.18±1.12 1.86±1.65 4.40±0.26 
FK2 6.00±0.00 0.48±0.10 95.45±1.35 1.91±1.44 4.53±0.22 
FK3 6.00±0.00 0.51±0.12 98.36±2.45 1.37±0.92 4.90±0.71 
FXK1 6.00±0.00 0.40±0.06 102.54±2.21 0.78±0.75 4.80±0.47 
FXK2 6.00±0.00 0.42±0.07 103.16±2.07 1.10±0.76 5.00±0.42 
FXK3 6.00±0.00 0.30±0.03 100.80±2.25 1.41±0.99 5.20±0.40 
      
Kinetic analysis of release data of tablets  
Drug release kinetics The Korsmeyer and Peppas equation 
was used to analyze the data obtained from the in-vitro 
release studies to evaluate the kinetic models and release 
mechanism of Aceclofenac from the matrices. The software 
PCP Disso V2.08 was used.   
 Korsmeyer and Peppas equation (Korsmeyer and Peppas, 
1981) is:  
Mt/ M∞   = ktn 
Where Mt/M∞ is the fraction of drug release at time t, k is a 
constant incorporating the properties of the macromolecular 
polymeric system and the drug. The n is an exponent used to 
characterize the transport mechanism. For example, n = 0.45 
for Case I or Fickian diffusion, 0.45 < n < 0.89 for 
anomalous behaviour or non-Fickian transport, n = 0.89 for 
Case II transport, and n > 0.89 for Super Case II transport. 
Fickian diffusional release occurs by the usual molecular 
diffusion of the drug due to a chemical potential gradient. 
Case II relaxational release is the drug transport mechanism 
associated with stresses and state-transition in hydrophilic 
glassy polymers, which swell in water or biological fluids.  
Case II generally refers to erosion of polymeric chain and 
anomalous transport (non-fickian) refers to a combination of 
both diffusion and erosion controlled drug release.1,3 
RESULT AND DISCUSSION 
Analysis of Aceclofenac matrices the tablets with weight of 
400 mg, a diameter of 9.0 mm and height of 6.0 mm were 
obtained and subjected to quality control tests such as 
hardness, friability and drug content (table 1). The contents 
of the formulations were found to be uniform, since the 
amount of the active ingredient in each of the 10 units tested 
was within the range of 92.85 ± 2.4 - 100.80 ± 2.25 %, 
indicating uniform mixing of gums, Starch-1500 and drug. 
The mean values for hardness were over 5.2 kg/cm2 and all 
formulations exhibits friability less than 0.4% during the 
friability determination.   
In-vitro drug release  
The aqueous medium on contact with hydrophilic polymer 
matrix gradually begins to hydrate from the peripheral 
towards the centre, forming a gelatinous swollen mass, 
which controls the diffusion of drug molecules through the 
polymeric material into aqueous medium. The hydrated gel 
layer thickness determines the diffusional path length of 
drug.  
The in-vitro drug release profiles of Aceclofenac from tablets 
containing FX, FK and FXK in different gum proportions are 
shown in Figure-1 respectively. After 2h, the initial pH 1.2 
was changed to pH7.4 continue the dissolution up to 24 h. It 
was shown that as the amount of gum in the matrix 
increased, there would be a greater degree of gum hydration 
with simultaneous swelling. This resulted in corresponding 
lengthening of the drug diffusion pathway and drug release 
rate.  
Drug release was generally linear for most of the 
formulations, especially FXK matrices. Such linear release 
was from hydrophilic matrices has been attributed to 
synchronization between swelling and erosion of the polymer 
in maintaining a constant gel layer. FK is a nonionic 
polysaccharide and their hydration process is independent of 
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pH. During the test, all the formulation swelled and the outer 
layer of most of tablets appeared to be hydrated after being 
placed in dissolution medium. 
 
 
 
 
Figure 1: In vitro release profile of Aceclofenac from tablets containing drug: gum, 1:0.500, 1:0.625 and 1:0.750 ratios of (FX) 
Xanthan gum (FK) Karaya gum and (FXK) Mixture of Xanthan and Karaya gum. 
The profiles of the formulation of FX, FK, FXK, and the 
erosion and drug release at different drug: gum ratios of 
1:0.500, 1:0.625 and 1:0.750 are shown in figure-1.  In each 
case of FX there was an initial burst of xanthan gum erosion 
from the matrices during the acidic pH thereafter, the erosion 
of xanthan gum slowed considerably. It follows, therefore, 
that the hydrated xanthan gum network maintains its tight 
integrity with drug release by erosion and dissolution of the 
Singh et al                                        Journal of Drug Delivery & Therapeutics; 2012, 2(1)   21 
© 2011, JDDT. All Rights Reserved                                                                                                                                                                                     ISSN: 2250-1177 
drug accounting for most of the weight loss during the 
remainder of the experimental period. Furthermore, there is a 
greater burst of xanthan gum erosion in the formulation 
containing the lower proportion of xanthan gum in 1:0.625 
and 1:0.750 drugs: gum ratios. FK tablets formulations 
showed a higher tendency to loss of integrity than the FX and 
FXK. The swelling process of FK tablets was not uniform 
and the zones of high FK concentration appeared more 
swollen. In case of FK matrix a rapid erosion of the hydrated 
layer. This is because FK exhibit a less controlled release 
effect but has a synergistic action along with the xanthan 
gum and shows precise controlled release effect.    
In all the formulations, it has been observed that by increase 
the concentration of hydrophilic polymers in the 
formulations there by respectively retard the drug release 
form the matrices. In order to evaluate the role of FXK 
mixture, the drug release of Aceclofenac tablets with FX or 
FK alone, in same concentration of polysaccharide, was 
carried out and the results are shown in figure-1.  
 
 
 
Figure 2: Swelling behaviour of FX, FK, And FXK in drug: gum ratio of 1:0.500, 1:0.625 and 1:0.750 at pH 7.4. Each point 
represents the mean value of five samples. 
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Table 4: Values of n (exponent for release kinetics) 
 
Formulation    (drug: gum)       n values          r²                Transport Mechanism 
 
FX1                  (1:0.500)            1.179          0.926                 Super case II 
FX2                  (1:0.625)            0.803          0.970                 Anomalous 
FX3                  (1:0.750)            1.074          0.955                 Super case II 
FK1                  (1:0.500)            1.297          0.989                 Super case II 
FK2                  (1:0.625)            1.191          0.987                 Super case II 
FK3                  (1:0.750)            0.776          0.991                 Anomalous 
FXK1               (1:0.500)            1.196          0.917                 Super case II 
FXK2               (1:0.625)            1.378          0.948                 Super case II 
FXK3               (1:0.750)            0.993          0.959                 Super case II 
 
r2 determination coefficient. 
FX (xanthan gum), FK (karaya gum), FXK (xanthan gum and Karaya gum mixture in 1:1 ratio). 
 
 
   
Figure-3 Release kinetics of Aceclofenac formulation from (FX) Xanthan gum; (FK) karaya gum and (FXK) Mixture of 
Xanthan and karaya gum 
Singh et al                                        Journal of Drug Delivery & Therapeutics; 2012, 2(1)   23 
© 2011, JDDT. All Rights Reserved                                                                                                                                                                                     ISSN: 2250-1177 
The drug release was slower from the matrices with FXK 
compared to FX and FK matrices with the same total 
polymer concentration. The release of FX and FXK was 
similar but in case of FX the release of Aceclofenac at low 
concentration of xanthan gum a starting burst effect of 
release was seen in acidic pH. In case of FXK this type of 
burst effect was not seen in acidic pH. The FXK 
formulations exhibits good controlled release effect by the 
utilization of synergistic interaction between two 
biopolymers to produce a strong and elastic gel around the 
core of the matrices in the presence of a ternary component 
there by control the drug release form the matrices 
containing FXK formulation. Thereby FXK formulations 
show precise control release. 
Swelling behaviour studies  
The swelling behaviour studies were carried out with 
XLBG3 formulation of drug:gum ratio of 1:0.750, which 
resulted in the better dissolution profile. The results of 
swelling and erosion tests were shown in fig.2. The swelling 
behaviour indicates the rate at which this formulation absorbs 
water from dissolution media and swells. The change in 
weight is characteristic of water uptake and swelling, started 
from the beginning and continued until 8 h of experiment 
(figure-2)(3,10) 
Determination of the release kinetics  
To evaluate the drug release kinetics, formulations showing a 
significant slow release were chosen. In general, the 
mechanism of drug release from polymeric matrices can be 
described by the swelling phenomenon. The solvent 
molecules move inside the polymeric matrix like a “front” 
defined at an exact speed; simultaneously, the thickness of 
the area increased with time in the opposite direction. The 
mechanism of drug release can be described by a second 
phenomenon that involves the disentanglement and erosion 
of the polymer. The release process involves the penetration 
of water into dry matrix followed by hydration and swelling 
of the polymer, and diffusion of the drug dissolved in the 
matrix.  
By using Korsmeyer and Peppas (Korsmeyer and Peppas, 
1981) Equation, the n values were obtained between 0.77 and 
1.378 (table 3) for all formulations. These values are 
characteristic of anomalous kinetics (non Fickian) and super 
case –II transport, suggesting that more than one mechanism 
may be involved in release kinetics. The release pattern of 
Aceclofenac from different formulation was obtained by 
plotting log Mt/M∞ versus log time was shown in Figure-3. 
In case of FX and FXK of all formulations shows super case 
II transport kinetics.  
For all the Aceclofenac matrix formulations, the contribution 
of polymer relaxation occurs throughout the entire 
dissolution time period. This was also apparent from the n 
values obtained (table 3), which approaches Anomalous and 
super case-II transport.  In general, the relaxational 
contribution was higher for the formulations with higher n 
values. The FXK formulation showed the highest 
contribution of polymer relaxation, and swelling studies 
(figure-3). The formulations of FX and FK, showed the 
lowest n values, respectively then the FXK approaching less 
relaxational contribution. In the FXK3 formulation in the 
ratio of 1:0.750 reflects controlled delivery of Aceclofenac. 
FTIR studies  
The FTIR spectra of pure drug and formulation containing 
FXK are shown in figure-4. From the figure it is clear that 
the characteristic peaks at 3220(O-H stretching), 1717(C=O 
stretching), 1507(C-C stretching), 750(C-Cl stretching) cm-1 
have been appeared in both the pure Aceclofenac drug and its 
formulation containing FXK matrices, without any change in 
their peak position, indicating no chemical interaction 
between and FXK as confirmed by the FTIR studies
.  
 
Figure 4: FITR Spectral obtained for pure drug and formulation containing FXK 
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CONCLUSION   
The tablets with FXK resulted in more uniform controlled 
drug release matrices than FX and FK control the drug 
release process and the smallest average size of the particles. 
Xanthan gum matrices had marked sustained effect on the 
release of Aceclofenac than FK alone matrices. The FXK 
formulation was found to provide the required release rate, 
with zero-order release kinetics, it cost effective and more 
similar to reference standard. There was no chemical 
interaction between drug and polymer as been confirmed by 
FTIR studies. At the same total concentration, the FX 
matrices did not show controlled release but the FK has 
synergistic action with the xanthan shows precise controlled 
release effect. The predominant release mechanism varied 
with matrices composition and drug release was controlled 
by both diffusion and relaxation, with predominance of the 
latter mechanism mainly in FXK tablets. 
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